254 filings
8-K
CARA
Cara Therapeutics Inc
18 Jun 24
Cost Associated with Exit or Disposal Activities
4:16pm
8-K
CARA
Cara Therapeutics Inc
12 Jun 24
Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica
5:12pm
424B5
CARA
Cara Therapeutics Inc
7 Jun 24
Prospectus supplement for primary offering
4:10pm
8-K
CARA
Cara Therapeutics Inc
7 Jun 24
Amendments to Articles of Incorporation or Bylaws
4:05pm
10-Q
2024 Q1
CARA
Cara Therapeutics Inc
Quarterly report
13 May 24
4:17pm
8-K
c8m7mtsv
13 May 24
Cara Therapeutics Reports First Quarter 2024 Financial Results
4:10pm
DEFA14A
221mn1oixo g33w9oi
22 Apr 24
Additional proxy soliciting materials
4:08pm
ARS
ugow wsyol2vpcyp
22 Apr 24
Annual report to shareholders
4:07pm
PRE 14A
x7zc w2zfk7g711smka
12 Apr 24
Preliminary proxy
4:15pm
8-K
b7p2hivs co
22 Mar 24
Departure of Directors or Certain Officers
4:05pm
S-8
sagtxwml57r
6 Mar 24
Registration of securities for employees
4:45pm
8-K
e8xfifcb3zwh7zmbv
4 Mar 24
Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
4:10pm
8-K
x8pfajnio 1w32
2 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:59pm
8-K
x157ag
22 Jan 24
Cost Associated with Exit or Disposal Activities
4:19pm
8-K
y1g20ze4ecz
18 Dec 23
Regulation FD Disclosure
7:10am
8-K
60uxt3
13 Nov 23
Corporate Presentation November 2023
4:28pm
8-K
i4ax4ctyjshytm1a
13 Nov 23
Cara Therapeutics Reports Third Quarter 2023 Financial Results
4:11pm